Detailed information
| LncRNA Name | GAS5 |
| Variant Type | SNP |
| Variant ID | rs145204276 |
| Species | human |
| Circulating | ✓ |
| Survival | ✕ |
| CeRNA | ✓ |
| Methylation | ✓ |
| Enhancer | ✕ |
| Drug | ✕ |
| Disease/Trait | febrile convulsion |
| LncRNA Target Gene | NA |
| Tissue | blood |
| Experiment | quantitative reverse‐transcription polymerase chain reaction, immunohistochemistry assays |
| Function Description | Rs145204276 is an SNP situated in the promoter region of GAS5, and the DEL/DEL genotype of rs145204276 could increase the transcription efficiency of GAS5 promoter |
| Pubmed ID | 30656683 |
| Year | 2019 |
| Title | Association between indel polymorphism (rs145204276)in the promoter region of lncRNA GAS5 and the risk of febrile convulsion |
| External Links | |
|---|---|
| Links For GAS5 | GeneCards HGNC NONCODE LncRNAWiki lncrnadb |
| Links For febrile convulsion | OMIM Cosmic |
| Links For rs145204276 | dbSNP ClinVar OMIM |